207 related articles for article (PubMed ID: 29480020)
1. Protective effects of quercetin treatment in a pristane-induced mouse model of lupus nephritis.
Dos Santos M; Poletti PT; Favero G; Stacchiotti A; Bonomini F; Montanari CC; Bona SR; Marroni NP; Rezzani R; Veronese FV
Autoimmunity; 2018 Mar; 51(2):69-80. PubMed ID: 29480020
[TBL] [Abstract][Full Text] [Related]
2. Oral supplementation of melatonin protects against lupus nephritis renal injury in a pristane-induced lupus mouse model.
Dos Santos M; Favero G; Bonomini F; Stacchiotti A; Rodella LF; Veronese FV; Rezzani R
Life Sci; 2018 Jan; 193():242-251. PubMed ID: 29097157
[TBL] [Abstract][Full Text] [Related]
3. Vitamin D supplementation ameliorates arthritis but does not alleviates renal injury in pristane-induced lupus model.
Correa Freitas E; Evelyn Karnopp T; de Souza Silva JM; Cavalheiro do Espírito Santo R; da Rosa TH; de Oliveira MS; da Costa Gonçalves F; de Oliveira FH; Guilherme Schaefer P; André Monticielo O
Autoimmunity; 2019 Mar; 52(2):69-77. PubMed ID: 31088305
[TBL] [Abstract][Full Text] [Related]
4. Baicalein ameliorates pristane-induced lupus nephritis via activating Nrf2/HO-1 in myeloid-derived suppressor cells.
Li D; Shi G; Wang J; Zhang D; Pan Y; Dou H; Hou Y
Arthritis Res Ther; 2019 Apr; 21(1):105. PubMed ID: 31023362
[TBL] [Abstract][Full Text] [Related]
5. Endogenous interleukin (IL)-17A promotes pristane-induced systemic autoimmunity and lupus nephritis induced by pristane.
Summers SA; Odobasic D; Khouri MB; Steinmetz OM; Yang Y; Holdsworth SR; Kitching AR
Clin Exp Immunol; 2014 Jun; 176(3):341-50. PubMed ID: 24528105
[TBL] [Abstract][Full Text] [Related]
6. Oxidative stress and immune complexes: Pathogenic mechanisms in pristane induced murine model of lupus.
Pannu N; Bhatnagar A
Immunobiology; 2020 Jan; 225(1):151871. PubMed ID: 31780314
[TBL] [Abstract][Full Text] [Related]
7. Suppression of Autoimmunity and Renal Disease in Pristane-Induced Lupus by Myeloperoxidase.
Odobasic D; Muljadi RC; O'Sullivan KM; Kettle AJ; Dickerhof N; Summers SA; Kitching AR; Holdsworth SR
Arthritis Rheumatol; 2015 Jul; 67(7):1868-80. PubMed ID: 25777776
[TBL] [Abstract][Full Text] [Related]
8. Vasoactive intestinal peptide ameliorates renal injury in a pristane-induced lupus mouse model by modulating Th17/Treg balance.
Fu D; Senouthai S; Wang J; You Y
BMC Nephrol; 2019 Sep; 20(1):350. PubMed ID: 31488076
[TBL] [Abstract][Full Text] [Related]
9. NLRP3 Inflammasome Modulation by Melatonin Supplementation in Chronic Pristane-Induced Lupus Nephritis.
Bonomini F; Dos Santos M; Veronese FV; Rezzani R
Int J Mol Sci; 2019 Jul; 20(14):. PubMed ID: 31311094
[TBL] [Abstract][Full Text] [Related]
10. Expression of XBP1s in B lymphocytes is critical for pristane-induced lupus nephritis in mice.
Xiang L; Liu A; Xu G
Am J Physiol Renal Physiol; 2020 May; 318(5):F1258-F1270. PubMed ID: 32249615
[TBL] [Abstract][Full Text] [Related]
11. Nephritogenic autoantibodies but absence of nephritis in Il-12p35-deficient mice with pristane-induced lupus.
Calvani N; Satoh M; Croker BP; Reeves WH; Richards HB
Kidney Int; 2003 Sep; 64(3):897-905. PubMed ID: 12911539
[TBL] [Abstract][Full Text] [Related]
12. Preclinical Testing of Viral Therapeutic Efficacy in Pristane-Induced Lupus Nephritis and Diffuse Alveolar Hemorrhage Mouse Models.
Guo Q; Zhang L; Yaron JR; Burgin M; Schutz LN; Awo EA; Lucas AR
Methods Mol Biol; 2021; 2225():241-255. PubMed ID: 33108667
[TBL] [Abstract][Full Text] [Related]
13. Toll-like receptor 2 is required for autoantibody production and development of renal disease in pristane-induced lupus.
Urbonaviciute V; Starke C; Pirschel W; Pohle S; Frey S; Daniel C; Amann K; Schett G; Herrmann M; Voll RE
Arthritis Rheum; 2013 Jun; 65(6):1612-23. PubMed ID: 23450347
[TBL] [Abstract][Full Text] [Related]
14. Iguratimod ameliorates nephritis by modulating the Th17/Treg paradigm in pristane-induced lupus.
Xia Y; Fang X; Dai X; Li M; Jin L; Tao J; Li X; Wang Y; Li X
Int Immunopharmacol; 2021 Jul; 96():107563. PubMed ID: 33812258
[TBL] [Abstract][Full Text] [Related]
15. Role of Lgals9 Deficiency in Attenuating Nephritis and Arthritis in BALB/c Mice in a Pristane-Induced Lupus Model.
Zeggar S; Watanabe KS; Teshigawara S; Hiramatsu S; Katsuyama T; Katsuyama E; Watanabe H; Matsumoto Y; Kawabata T; Sada KE; Niki T; Hirashima M; Wada J
Arthritis Rheumatol; 2018 Jul; 70(7):1089-1101. PubMed ID: 29481735
[TBL] [Abstract][Full Text] [Related]
16. Podocyte-associated mRNA profiles in kidney tissue and in urine of patients with active lupus nephritis.
dos Santos M; Bringhenti RN; Rodrigues PG; do Nascimento JF; Pereira SV; Zancan R; Monticielo OA; Gasparin AA; de Castro WP; Veronese FV
Int J Clin Exp Pathol; 2015; 8(5):4600-13. PubMed ID: 26191151
[TBL] [Abstract][Full Text] [Related]
17. Modulation of the immune response in pristane-induced lupus by expression of activation and inhibitory Fc receptors.
Clynes R; Calvani N; Croker BP; Richards HB
Clin Exp Immunol; 2005 Aug; 141(2):230-7. PubMed ID: 15996187
[TBL] [Abstract][Full Text] [Related]
18. Retinoic Acid Exerts Disease Stage-Dependent Effects on Pristane-Induced Lupus.
Abdelhamid L; Cabana-Puig X; Swartwout B; Lee J; Li S; Sun S; Li Y; Ross AC; Cecere TE; LeRoith T; Werre SR; Wang H; Reilly CM; Luo XM
Front Immunol; 2020; 11():408. PubMed ID: 32265909
[TBL] [Abstract][Full Text] [Related]
19. Pristane-Accelerated Autoimmune Disease in (SWR X NZB) F1 Mice Leads to Prominent Tubulointerstitial Inflammation and Human Lupus Nephritis-Like Fibrosis.
Gardet A; Chou WC; Reynolds TL; Velez DB; Fu K; Czerkowicz JM; Bajko J; Ranger AM; Allaire N; Kerns HM; Ryan S; Legault HM; Dunstan RW; Lafyatis R; Lukashev M; Viney JL; Browning JL; Rabah D
PLoS One; 2016; 11(10):e0164423. PubMed ID: 27760209
[TBL] [Abstract][Full Text] [Related]
20. Effects of
Cheng L; Yao P; Wang H; Yuan Q; Wang X; Feng W; Sun F; Wang Q
Drug Des Devel Ther; 2022; 16():2851-2860. PubMed ID: 36051155
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
